ArticleFrontiers in pharmacology2021

Cost-Effectiveness of Domestic PD-1 Inhibitor Camrelizumab Combined With Chemotherapy in the First-Line Treatment of Advanced Nonsquamous Non-Small-Cell Lung Cancer in China.

Liu Qiao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.